🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07199101
Starting soon Not applicable

Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification

NCT07199101 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Children's Hospital
Phase
Not applicable
Started
2026-01-01
Last updated
2025-09-30

Condition(s) studied

Radiation Dose Reduction

Investigational drug(s) / intervention(s)

Low dose CT

Low dose CT: Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on low dose simulation technique.

Study summary

Children are sensitive to ionizing radiation, and there are significant regional variations in current pediatric CT radiation doses. Although there are studies on low-dose CT targeting single lesions, these studies require clear clinical indications and support from advanced equipment, making widespread promotion difficult. The establishment of low-dose CT protocols is mostly experience-based; when radiologists lack confidence in image quality, the credibility of diagnostic reports is compromised. Therefore, the development of low-dose protocols must meet the diagnostic confidence of most radiologists, enable clear visualization of key anatomical structures in clinical practice, and satisfy the requirements for disease diagnosis.

The purpose of this study is to establish a pediatric low-dose CT scanning protocol using Low-dose Simulation of CT (LDS) technology, and conduct a multicenter randomized controlled trial (RCT) in clinical settings to verify the clinical feasibility of this low-dose CT scanning protocol.

Eligibility

Sex
ALL
Min age
0 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 0-17 years. * Pediatric patients for whom a CT examination is deemed necessary by an attending physician. Exclusion Criteria: * Parents/guardians refuse to consent to low-dose CT examination. * Pediatric patients are in critical condition, with no time allocated for explanation of the randomized controlled trial (RCT) protocol.

Primary outcome measure(s)

Trial sites (20)

FacilityCityRegionStatus
Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing Beijing Municipality
Beijing Friendship Hospital, Capital Medical University Beijing Beijing Municipality
Beijing Tongren Hospital, Capital Medical University Beijing Beijing Municipality
Medical Center for Capital Children's Health, Capital Medical University Beijing Beijing Municipality
National Institute for Radiological Protection, China CDC Beijing Beijing Municipality
Peking Union Medical College Hospital Beijing Beijing Municipality
Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Chongqing Municipality
Guangdong Women and Children Hospital Guangzhou Guangdong
Nanfang Hospital, Southern Medical University Guangzhou Guangdong
Baoding Hospital, Beijing Children's Hospital Affiliated to Capital Medical University Baoding Heibei
Fuwai Central China Cardiovascular Hospital Zhengzhou Henan
The Third Affiliated Hospital of Zhengzhou University Zhengzhou Henan
Affiliated Women's Hospital of Jiangnan University Wuxi Jiangsu
Children's Hospital of Changchun Changchun Jilin
the First Hospital of Jilin University Changchun Jilin
The First Affiliated Hospital of Xi'an Jiao Tong University Xi'an Shaanxi
Shanghai Children's Medical Center, School of Medicine Shanghai Shanghai Municipality
Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality
ShanghaiTech University Shanghai Shanghai Municipality
People's Hospital of Xinjiang Uygur Autonomous Region Ürümqi Xinjiang

More Beijing Children's Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07199101 on ClinicalTrials.gov ↗ ← All trials in China